BioCryst Pharmaceuticals | BCRX - PE Price to Earnings


BioCryst Pharmaceuticals reported 6.84 in PE Price to Earnings for its fiscal quarter ending in June of 2026.





Pe Change Date
Alnylam Pharmaceuticals 75.64 4.4 Jun/2026
BioCryst Pharmaceuticals 6.84 0.78 Jun/2026
Chugai Pharma 24.32 4.56 Jun/2026
Daiichi Sankyo 20.14 0.6 Jun/2026
Gilead Sciences 13.51 4.2 Jun/2026
GlaxoSmithKline 10.63 4.24 Jun/2026
Glaxosmithkline 15.09 3.43 Mar/2026
Incyte 14.45 0.9 Jun/2026
Ionis Pharmaceuticals 396.15 79.28 Sep/2022
Neurocrine Biosciences 22.1 5.99 Jun/2026
Novavax 2.01 1.07 Dec/2025
PTC Therapeutics 8.76 1.22 Mar/2026
Regeneron Pharmaceuticals 15.46 9.68 Jun/2026
Roche Holding 16.48 0.39 Jun/2026
Sarepta Therapeutics 27.27 0 Mar/2026
Vertex Pharmaceuticals 28.05 2.22 Jun/2026